La maladie de Parkinson en France (serveur d'exploration) - Corpus (Istex)

Index « Auteurs » - entrée « C. Warren Olanow »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
C. Walon < C. Warren Olanow < C. Weiller  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000080 (2013) Erwan Bézard ; C. Warren Olanow ; José A. ObesoLevodopa–induced dyskinesias in the absence of nigrostriatal degeneration
000B80 (2012) Andrew Lees ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic ; Anthony Lang ; Federico Micheli ; M. Maral Mouradian ; Wolfgang H. Oertel ; C. Warren Olanow ; Werner Poewe ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh KumarPerampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease
000D45 (2010) Fabrizio Stocchi ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic ; Eduardo Tolosa ; Paulo Barone ; Anthony E. Lang ; C. Warren OlanowInitiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study
001278 (2000) C. Warren Olanow ; Anthony H. V. Schapira ; Olivier RascolContinuous dopamine-receptor stimulation in early Parkinson's disease
001841 (2004) C. Warren Olanow ; Yves Agid ; Yoshi Mizuno ; Alberto Albanese ; U. Bonucelli ; Philip Damier ; Justo De Yebenes ; Oscar Gershanik ; Mark Guttman ; F. Grandas ; Mark Hallett ; Ole Hornykiewicz ; Peter Jenner ; R. Katzenschlager ; William J. Langston ; Peter Lewitt ; Eldad Melamed ; M. A. Mena ; P. P. Michel ; Catherine Mytilineou ; Jose A. Obeso ; Werner Poewe ; Niall Quinn ; R. Raisman-Vozari ; Ali H. Rajput ; Olivier Rascol ; Christina Sampaio ; Fabrizio StocchiLevodopa in the treatment of Parkinson's disease: Current controversies
001863 (2008) Christopher G. Goetz ; Barbara C. Tilley ; Stephanie R. Shaftman ; Glenn T. Stebbins ; Stanley Fahn ; Pablo Martinez-Martin ; Werner Poewe ; Cristina Sampaio ; Matthew B. Stern ; Richard Dodel ; Bruno Dubois ; Robert Holloway ; Joseph Jankovic ; Jaime Kulisevsky ; Anthony E. Lang ; Andrew Lees ; Sue Leurgans ; Peter A. Lewitt ; David Nyenhuis ; C. Warren Olanow ; Olivier Rascol ; Anette Schrag ; Jeanne A. Teresi ; Jacobus J. Van Hilten ; Nancy LapelleMovement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results
001A21 (2007) Bruno Dubois ; David Burn ; Christopher Goetz ; Dag Aarsland ; Richard G. Brown ; Gerald A. Broe ; Dennis Dickson ; Charles Duyckaerts ; Jefferey Cummings ; Serge Gauthier ; Amos Korczyn ; Andrew Lees ; Richard Levy ; Irene Litvan ; Yoshikuni Mizuno ; Ian G. Mckeith ; C. Warren Olanow ; Werner Poewe ; Cristina Sampaio ; Eduardo Tolosa ; Murat EmreDiagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
001A98 (2007) Christopher G. Goetz ; Stanley Fahn ; Pablo Martinez-Martin ; Werner Poewe ; Cristina Sampaio ; Glenn T. Stebbins ; Matthew B. Stern ; Barbara C. Tilley ; Richard Dodel ; Bruno Dubois ; Robert Holloway ; Joseph Jankovic ; Jaime Kulisevsky ; Anthony E. Lang ; Andrew Lees ; Sue Leurgans ; Peter A. Lewitt ; David Nyenhuis ; C. Warren Olanow ; Olivier Rascol ; Anette Schrag ; Jeanne A. Teresi ; Jacobus J. Van Hilten ; Nancy LapelleMovement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan
001B15 (2008) Christopher G. Goetz ; Eugene Laska ; Christine Hicking ; Philippe Damier ; Thomas Müller ; John Nutt ; C. Warren Olanow ; Olivier Rascol ; Hermann RussPlacebo influences on dyskinesia in Parkinson's disease
001B17 (2013) C. Warren Olanow ; Karl Kieburtz ; Olivier Rascol ; Werner Poewe ; Anthony H. Schapira ; Murat Emre ; Helena Nissinen ; Mika Leinonen ; Fabrizio StocchiFactors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease
001C12 (2008) C. Warren Olanow ; Robert A. Hauser ; Joseph Jankovic ; William Langston ; Anthony Lang ; Werner Poewe ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier RascolA randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
001C50 (2007) Christopher G. Goetz ; Philippe Damier ; Christine Hicking ; Eugene Laska ; Thomas Müller ; C. Warren Olanow ; Olivier Rascol ; Hermann RussSarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i -k "C. Warren Olanow" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i  \
                -Sk "C. Warren Olanow" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    C. Warren Olanow
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024